Time is running out to get a $100 early bird discount for Xconomy’s latest biotech party in the Big Apple: New York Biotech Seizes the Momentum, at the Alexandria Center for Life Science on May 31.
For New York biotech, the future is now. City and state governments have heard the call and committed $1.15 billion to the life sciences scene—and vowed to bring more lab space online to start and grow local companies. A growing number of biotech incubators are popping up. Venture firms are on the ground scouting universities for big ideas. A concerted effort has begun statewide to show that New York is now taking the life sciences very seriously. Who are the key decision makers driving this effort forward? How can New York ensure that it all leads to real change for the state’s biotech identity? And what needs to be done to maximize the momentum—especially in the near-term?
Speakers include:
- Harold Varmus, Nobel Laureate; Professor, Weill Cornell Medical College; Co-chair, LifeSci NYC advisory council
- Eric Schadt, Chair, Department of Genetics and Genomic Sciences at Mount Sinai School of Medicine; Founder, Sema4
- Mike Foley, Sanders Director, Tri-Institutional Therapeutics Discovery Institute
- Gordana Vunjak-Novakovic, Professor, Columbia University
- Jason Park, Principal, Flagship Pioneering
- Piraye Beim, Founder & CEO, Celmatix
- Masoud Tavazoie, Co-founder & CEO, Rgenix
- Jenna Foger, Senior Principal, Science & Technology, Alexandria Venture Investments
Xconomy’s early bird rate ends tonight at midnight—register today and save $100 on regular registration.